Blueprint Medicines Corporation
BPMC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $102 | $71 | $120 | $210 |
| Short-Term Investments | $513 | $639 | $825 | $267 |
| Receivables | $78 | $43 | $37 | $37 |
| Inventory | $14 | $21 | $30 | $22 |
| Other Curr. Assets | $36 | $33 | $35 | $18 |
| Total Curr. Assets | $743 | $808 | $1,047 | $554 |
| Property Plant & Equip (Net) | $101 | $116 | $115 | $121 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $277 | $84 | $161 | $558 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $59 | $41 | $27 | $20 |
| Total NC Assets | $437 | $241 | $303 | $698 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,180 | $1,049 | $1,350 | $1,252 |
| Liabilities | – | – | – | – |
| Payables | $7 | $5 | $3 | $8 |
| Short-Term Debt | $57 | $81 | $27 | $16 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $64 | $1 | $449 | $37 |
| Other Curr. Liab. | $133 | $128 | $153 | $114 |
| Total Curr. Liab. | $261 | $215 | $183 | $150 |
| LT Debt | $412 | $693 | $215 | $103 |
| Deferred Rev, NC | $202 | $5 | $427 | $25 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $7 | $6 | $437 | $3 |
| Total NC Liab. | $620 | $704 | $652 | $132 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $82 | $94 | $103 | $111 |
| Total Liabilities | $881 | $919 | $835 | $281 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$2,407 | -$2,340 | -$1,833 | -$1,275 |
| AOCI | -$4 | -$3 | -$10 | -$4 |
| Other Equity | $2,709 | $2,474 | $2,358 | $2,250 |
| Total Equity | $299 | $131 | $515 | $971 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,180 | $1,049 | $1,350 | $1,252 |
| Net Debt | $367 | $703 | $123 | -$90 |